PE20150713A1 - Derivados de acido hialuronico modificados y uso de los mismos - Google Patents

Derivados de acido hialuronico modificados y uso de los mismos

Info

Publication number
PE20150713A1
PE20150713A1 PE2015000465A PE2015000465A PE20150713A1 PE 20150713 A1 PE20150713 A1 PE 20150713A1 PE 2015000465 A PE2015000465 A PE 2015000465A PE 2015000465 A PE2015000465 A PE 2015000465A PE 20150713 A1 PE20150713 A1 PE 20150713A1
Authority
PE
Peru
Prior art keywords
hyaluronic acid
acid derivatives
modified hyaluronic
compounds
carbon atoms
Prior art date
Application number
PE2015000465A
Other languages
English (en)
Spanish (es)
Inventor
Pietro Antonino Di
Francesca Cavazza
Paolo Caliceti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20150713(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PE20150713A1 publication Critical patent/PE20150713A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
PE2015000465A 2012-10-09 2013-10-07 Derivados de acido hialuronico modificados y uso de los mismos PE20150713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12187828 2012-10-09

Publications (1)

Publication Number Publication Date
PE20150713A1 true PE20150713A1 (es) 2015-05-16

Family

ID=47022522

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000465A PE20150713A1 (es) 2012-10-09 2013-10-07 Derivados de acido hialuronico modificados y uso de los mismos

Country Status (21)

Country Link
US (1) US20150252120A1 (enExample)
EP (1) EP2906193B1 (enExample)
JP (1) JP2015533190A (enExample)
KR (1) KR20150065861A (enExample)
CN (1) CN104703583A (enExample)
AR (1) AR092922A1 (enExample)
AU (1) AU2013328842A1 (enExample)
BR (1) BR112015007823A2 (enExample)
CA (1) CA2886144A1 (enExample)
CL (1) CL2015000803A1 (enExample)
EA (1) EA201590708A1 (enExample)
HK (1) HK1210941A1 (enExample)
IL (1) IL238103A0 (enExample)
IN (1) IN2015DN02358A (enExample)
MX (1) MX2015004386A (enExample)
PE (1) PE20150713A1 (enExample)
PH (1) PH12015500585A1 (enExample)
SG (1) SG11201501992XA (enExample)
TW (1) TW201414478A (enExample)
WO (1) WO2014056841A1 (enExample)
ZA (1) ZA201503171B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI614005B (zh) * 2014-05-26 2018-02-11 National Taipei University Of Technology 水膠組合物的用途
DE202014008682U1 (de) * 2014-07-11 2015-08-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
EP3397241A1 (en) * 2015-12-30 2018-11-07 Asafov, Alexander Vilenovich Formulation for treatment of peripheral joints, spinal joints and/or extracellular matrix elements of connective tissue, method of manufacture and uses
RU2625766C1 (ru) * 2016-07-19 2017-07-18 Александр Ливиевич Ураков Средство для экстренного восстановления голоса при внезапной афонии
CN116891540A (zh) * 2018-03-22 2023-10-17 持田制药株式会社 连接有非甾体抗炎化合物的海藻酸衍生物
EP3793525A4 (en) * 2018-05-16 2022-02-16 Emory University PALLADIUM HYALURONIC ACID PARTICLES AND METHODS OF MANAGEMENT OF CANCER OR ANGIOGENIC DISEASES
CN119176959B (zh) * 2024-09-18 2025-07-04 云南贝泰妮生物科技集团股份有限公司 一种透明质酸-聚乳酸共聚物交联凝胶及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8713662D0 (en) 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
US4839159A (en) 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1251151B (it) 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6585987B1 (en) 1998-11-13 2003-07-01 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
CA2445985A1 (en) 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
ITMI20021666A1 (it) 2002-07-26 2004-01-26 Jasper Ltd Liability Co Derivati dell'acido ialuronico
US20110027357A1 (en) * 2004-02-18 2011-02-03 Isaac Gilinski Compositions and methods for timed release of water-soluble nutritional supplements
US20060134147A1 (en) 2004-12-21 2006-06-22 Avon Products, Inc. Cosmetic compositions having carnitine creatinate and methods for using
CA2593064A1 (en) 2004-12-30 2006-07-06 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
JP5047507B2 (ja) * 2005-09-30 2012-10-10 昭和電工株式会社 カルニチン誘導体及びその塩、皮膚外用剤ならびに化粧料
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
EP1884231A1 (en) 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
CN101677912B (zh) 2007-05-11 2013-06-12 希格马托制药工业公司 可用于递送化妆品活性成分的凝胶
EP2162158A2 (en) 2007-05-23 2010-03-17 Allergan, Inc. Coated hyaluronic acid particles
WO2010003797A1 (en) 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing

Also Published As

Publication number Publication date
EP2906193B1 (en) 2016-09-28
TW201414478A (zh) 2014-04-16
CA2886144A1 (en) 2014-04-17
KR20150065861A (ko) 2015-06-15
BR112015007823A2 (pt) 2017-07-04
JP2015533190A (ja) 2015-11-19
US20150252120A1 (en) 2015-09-10
HK1210941A1 (en) 2016-05-13
ZA201503171B (en) 2016-11-30
AU2013328842A1 (en) 2015-04-09
PH12015500585A1 (en) 2015-05-04
IN2015DN02358A (enExample) 2015-09-04
SG11201501992XA (en) 2015-04-29
EP2906193A1 (en) 2015-08-19
WO2014056841A1 (en) 2014-04-17
AR092922A1 (es) 2015-05-06
IL238103A0 (en) 2015-05-31
CL2015000803A1 (es) 2015-08-07
CN104703583A (zh) 2015-06-10
MX2015004386A (es) 2015-06-10
EA201590708A1 (ru) 2015-07-30

Similar Documents

Publication Publication Date Title
CR20160272A (es) REGULADORES DE Nrf2
UY35700A (es) Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística
ECSP13012519A (es) Compuestos sustituidos de benzamida
BR112016007572A8 (pt) composição, composição de fixador para os cabelos e método para a produção uma poligalactomanana dihidroxipropil-substituída
DOP2015000054A (es) Derivados de c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso
BR112015000520A2 (pt) agente de espessamento estável com lipase
MX390762B (es) Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas
UY33526A (es) Nuevas aminopirazoloquinazolinas
CU20120099A7 (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
ECSP11011347A (es) Nicotinamida sustituida como moduladores KCNQ2/3
ECSP13012482A (es) Derivados de 5-yodo-triazol
PE20151928A1 (es) Instalacion para la preparacion de una solucion de carbonato acido de calcio adecuada para la remineralizacion del agua
ECSP13012573A (es) 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
CL2013000308A1 (es) Uso de compuestos heterociclicos con nitrogeno, oxigeno o azufre, para tratar una imperfeccion de la piel tal como una herida superficial, cicatriz o arruga; composiciones farmaceuticas.
AR092922A1 (es) Derivados de acido hialuronico modificados y uso de los mismos
NI201500050A (es) Benzamidas
BR112015008954A2 (pt) composições de ciclodextrina alquilatada e processos para preparação e uso das mesmas
GT201500247A (es) Imidazopiridazinas sustituidas
BR112015007422A2 (pt) novos compostos farmacêuticos
MX2014003840A (es) Metodo para reducir la transpiracion y composiciones antitranspirantes.
UY32404A (es) 4-aril-butan-1,3-diamidas
MX2015011497A (es) Gel de acido salicilico.
MX343517B (es) 2,4 pirimidinadiaminas sustituidas para su uso en lupus discoide.
UY33179A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2,5-sustituido.

Legal Events

Date Code Title Description
FD Application declared void or lapsed